Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunogenetics of multiple sclerosis: more questions than answers.
Immunological processes related to cognitive impairment in MS.
Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance.
Induction of gut regulatory CD39(+) T cells by teriflunomide protects against EAE.
Microglia-induced activation of non-canonical Wnt signaling aggravates neurodegeneration in demyelinating disorders.
Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury.
Anti-myelin oligodendrocyte glycoprotein antibody neuritis optica following anti-NMDA receptor encephalitis.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.
Retinal nerve fiber layer thickness by Stratus and Cirrus OCT in retrobulbar optic neuritis and nonarteritic ischemic optic neuropathy.
Ingested (oral) rituximab inhibits EAE.
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
Defining the microglia response during the time course of chronic neurodegeneration.
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.
Phenytoin for neuroprotection - Authors' reply.
Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
Peptidyl Aldehyde Specifically Interacts with Immunosubunit β1i Proteasome: In Vitro and In Vivo Effects.
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
Pages
« first
‹ previous
…
767
768
769
770
771
772
773
774
775
…
next ›
last »